AI-generated from publicly available materials.Caris Life Sciences has enlisted Kevin Costner to promote the critical role of early cancer detection through its new campaign for the Caris Detect blood test.
The initiative, titled “Math,” marks the first campaign for Caris Detect since its July launch. This multi-cancer early detection (MCED) test utilizes advanced AI to analyze DNA and RNA for cancer-related molecular signals in the bloodstream, offering a comprehensive view compared to traditional methods that focus on a limited number of biomarkers. The campaign emphasizes the stark contrast in survival rates between early-stage and late-stage cancer, with Costner illustrating that timely detection can significantly influence outcomes.
In the campaign, Costner presents the importance of early detection in a classroom setting, highlighting that stage one cancers can have survival rates exceeding 90%, whereas stage four often sees rates below 10%. His message is clear: the critical factor is “time.” Costner’s portrayal aims to convey that Caris Detect is a scientific advancement rather than a matter of chance, reinforcing the idea that early detection is synonymous with better survival odds.
Caris CEO David Dean Halbert praised Costner's authenticity and ability to resonate with diverse audiences, suggesting that his involvement could encourage proactive health measures. The company aims for Caris Detect to become the new standard for early cancer detection, positioning it alongside existing diagnostics like the Cancer Seek assay. As Caris continues to innovate, the collaboration with Costner may help raise awareness and drive adoption of these crucial early detection technologies.